van de Kerkhof, P C M <br/><br/>
The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.  [electronic resource] 

 -  The British journal of dermatology  Sep 2004 
 - 663-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0007-0963 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2133.2004.06134.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activities of Daily Living<br/>Adult<br/>Betamethasone--analogs & derivatives<br/>Calcitriol--analogs & derivatives<br/>Dermatologic Agents--therapeutic use<br/>Disability Evaluation<br/>Double-Blind Method<br/>Drug Combinations<br/>Female<br/>Health Status Indicators<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Psoriasis--drug therapy<br/>Quality of Life<br/>Treatment Outcome